Volume 11 Issue 5
Sep.  2020
Turn off MathJax
Article Contents
Zhu-ming JIANG, Zhuo LI, Yang WANG, Hui ZHANG, Yan WANG, Bin JIE, Hai FANG, Wei LI, Yan-wu ZHANG, Fen ZHANG, Tie-jun HU, Da-kui LI, Wei-ming KANG, Kang YU, Xin YE. Brief Review of the 3T's Roadmap of Translational Medicine for Parenteral and Enteral Nutrition in China[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(5): 508-513. doi: 10.3969/j.issn.1674-9081.2020.05.002
Citation: Zhu-ming JIANG, Zhuo LI, Yang WANG, Hui ZHANG, Yan WANG, Bin JIE, Hai FANG, Wei LI, Yan-wu ZHANG, Fen ZHANG, Tie-jun HU, Da-kui LI, Wei-ming KANG, Kang YU, Xin YE. Brief Review of the 3T's Roadmap of Translational Medicine for Parenteral and Enteral Nutrition in China[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(5): 508-513. doi: 10.3969/j.issn.1674-9081.2020.05.002

Brief Review of the 3T's Roadmap of Translational Medicine for Parenteral and Enteral Nutrition in China

doi: 10.3969/j.issn.1674-9081.2020.05.002
More Information
  • Till 2020, parenteral and enteral nutrition in China has moved from Translation 1 (T1), and then Translation 2 (T2), to Translation 3 (T3) now. The T3 transfer requires the evaluation of medical services' quality and cost-effectiveness research. After learning from international published articles, the multicenter cooperative database group of Chinese Society for Parenteral and Enteral Nutrition (CSPEN) on Nutritional risk, Undernutrition, Support, Outcome, and Cost-effectiveness ratio (NUSOC) (abbreviated to CSPEN-NUSOC Cooperative Group) has made efforts to promote health economics research in the field of parenteral and enteral nutrition in China. This paper reviewed the translational medical research of parenteral and enteral nutrition in China. At present, clinical studies toward the goal of "reasonable use to benefit patients"should be conducted in parenteral and enteral nutrition field in China, such as clinical effectiveness study of nutritional risk screening 2002 and Global Leadership Initiative on Malnutrition criteria, or health economics study on nutritional drug.
  • loading
  • [1] Choi DW. Bench to bedside: the glutamate connection[J]. Science, 1992, 258:241-243. doi:  10.1126/science.1357748
    [2] Mulshine JL, Jett M, Cuttitta F, et al. Scientific basis for cancer prevention intermediate cancer markers[J]. Cancer, 1993, 72: 978-983. doi:  10.1002/1097-0142(19930801)72:3+<978::AID-CNCR2820721305>3.0.CO;2-T
    [3] Geraghty J. Adenomatous polyposis coli and translational medicine[J]. Lancet, 1996, 348: 422. http://www.sciencedirect.com/science/article/pii/S0140673605645357
    [4] Zerhouni E. The NIH Roadmap[J]. Science, 2003, 302: 63-72. doi:  10.1126/science.1091867
    [5] Dougherty D, Conway PH. The "3T's" road map to transform US health care: the "how" of high-quality care[J]. JAMA, 2008, 299: 2319-2321. doi:  10.1001/jama.299.19.2319
    [6] 蒋朱明, 曾宪九, 朱预, 等.静脉高营养[M]//中国医学科学院首都医院.水与电解质平衡.北京: 人民卫生出版社, 1974: 477-489.
    [7] 蒋朱明, 朱预, 张思源.静脉营养治疗外科危重病人[C].中华医学会.第九届全国外科学术会议论文摘要, 1978: 273.
    [8] 蒋朱明, 朱预, 张思源, 等.静脉营养与要素饮食用于肠瘘[J].中华外科杂志, 1979, 17: 40-43. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhwk197901111
    [9] 吴肇汉, 吴肇光.外科重危病人应用静脉营养疗法的一些体会[J].上海医学, 1979, 2: 19-23. http://www.cnki.com.cn/Article/CJFDTotal-SHYX197901009.htm
    [10] 邹忠寿, 黎介寿, 顾寿年.静脉高价营养疗法在儿外科的应用[J].江苏医药, 1979:5-7. http://www.cnki.com.cn/Article/CJFDTotal-YIYA197905003.htm
    [11] 蒋耀光, 周月庆.要素饮食在外科临床的应用[J].人民军医, 1979, 30: 78-81. http://epub.cnki.net/grid2008/docdown/docdownload.aspx?filename=RMJZ197905038&dbcode=CJFD&year=1979&dflag=pdfdown
    [12] 雷政宏, 安娜, 郑渝英, 等.烧伤病人静脉高价营养护理[J].第三军医大学学报, 1979, 1: 120-123. http://www.cnki.com.cn/Article/CJFDTotal-DSDX197904024.htm
    [13] Braga M, Gianotti L. Preoperative immunonutrition: cost-benefit analysis[J]. JPEN J Parenter Enteral Nutr, 2005, 29: S57-S61. http://europepmc.org/abstract/MED/15709546
    [14] Jiang ZM, Chen W, Zhan WH, et al. Parenteral and enteral nutrition application in west, middle and east China: a multicenter investigation for 15098 patients in 13 metropolitans using nutritional risk screening 2002 tool[J]. Clin Nutr Suppl, 2007, 2:133-134.
    [15] 工信部.中国区块链技术和应用发展白皮书[R]. 2016: 23.
    [16] Liang XK, Jiang ZM, Nolan MT, et al. Comparative survey on nutritional risk and nutritional support between Beijing and Baltimore teaching hospitals[J]. Nutrition, 2008, 24: 969-976. doi:  10.1016/j.nut.2008.05.001
    [17] Liang XK, Jiang ZM, Nolan MT, et al. Nutritional risk, malnutrition (undernutrition), overweight, obesity and nutrition support among hospitalized patients in Beijing teaching hospitals[J]. Asia Pac J Clin Nutr, 2009, 18: 54-62. http://europepmc.org/abstract/MED/19329396
    [18] 蒋朱明, 于康, 朱赛楠, 等.我国东, 中, 西部中小医院住院患者营养不良(不足), 营养风险, 超重和肥胖发生率及营养支持应用状况调查(中期小结)[J].中国临床营养杂志, 2008, 16: 338-340. http://www.cnki.com.cn/Article/CJFDTotal-ZGLZ200806006.htm
    [19] 蒋朱明, 陈伟, 朱赛楠, 等.我国东、中、西部大城市三甲医院营养不良(不足)、营养风险发生率及营养支持应用状况调查[J].中国临床营养杂志, 2008, 16: 335-337. http://www.cnki.com.cn/article/cjfdtotal-zglz200806005.htm
    [20] Jie B, Jiang ZM, Nolan MT, et al. Impact of nutritional support on clinical outcome in patients at nutritional risk: a multicenter, prospective cohort study in Baltimore and Beijing teaching hospitals[J]. Nutrition, 2010, 26: 1088-1093. doi:  10.1016/j.nut.2009.08.027
    [21] Jie B, Jiang ZM, Nolan MT, et al. Impact of preoperative nutritional support on clinical outcome in abdominal surgical patients at nutritional risk[J]. Nutrition, 2012, 28: 1022-1027. doi:  10.1016/j.nut.2012.01.017
    [22] 王艳, 蒋朱明, 王杨, 等.营养支持对有营养风险胃肠病患者临床结局的影响以及成本-效果比初步探讨: 275例前瞻性队列研究[J].中华临床营养杂志, 2013, 21: 333-338. http://d.wanfangdata.com.cn/Periodical/zglcyyzz201306002
    [23] Zhang H, Wang Y, Jiang ZM, et al. Impact of nutrition support on clinical outcome and cost-effectiveness analysis in patients at nutritional risk: A prospective cohort study with propensity score matching[J]. Nutrition, 2017, 37: 53-59. doi:  10.1016/j.nut.2016.12.004
    [24] Kondrup J, Rasmussen HH, Hamberg O, et al. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials[J]. Clin Nutr, 2003, 22: 321-336. doi:  10.1016/S0261-5614(02)00214-5
    [25] Kondrup J, Allison SP, Elia M, et al. ESPEN guidelines for nutrition screening 2002[J]. Clin Nutr, 2003, 22: 415-421. doi:  10.1016/S0261-5614(03)00098-0
    [26] 刘国恩, 胡善联, 吴久鸿.中国药物经济学评价指南[J].中国药物经济学, 2011, 3: 6-48. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgywjjx201005001
    [27] 揭彬, 蒋朱明.肠外或肠内营养支持对有营养风险患者临床结局的影响[J].中华临床营养杂志, 2009, 17: 127-128. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zglcyyzz200902020
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)

    Article Metrics

    Article views (383) PDF downloads(46) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return